Sana Biotechnology, Inc., was incorporated in Delaware on July 13, 2018. The company is a biotechnology company that develops drugs using engineered cells. Its business includes identifying and developing potential product candidates, conducting preclinical research, and building production capabilities. Sana Biotechnology is also committed to the preparation and execution of clinical trials of its product candidates and provides support for clinical trials of product candidates developed using its technology. In addition, the company focuses on new technology acquisition, staffing, business planning, maintaining its intellectual property portfolio, raising capital and providing general administrative support for the above-mentioned tasks.
